Healing Study of Fractional Skin Resurfacing and Tissue Histopathology After Ellacor Treatment

NACompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

April 30, 2024

Primary Completion Date

May 17, 2024

Study Completion Date

May 17, 2024

Conditions
WrinkleRhytidesHistopathology
Interventions
DEVICE

ellacor® Micro-Coring procedure

ellacor® Micro-Coring Technology is FDA approved for use by medical professionals for the treatment of moderate and severe wrinkles in the mid and lower face in adults aged 22 years or older with Fitzpatrick skin types I-IV.

Trial Locations (1)

75231

Dallas Plastic Surgery Institute, Dallas

Sponsors
All Listed Sponsors
collaborator

Dallas Plastic Surgery Institute

OTHER

lead

Cytrellis Biosystems, Inc.

INDUSTRY

NCT06502470 - Healing Study of Fractional Skin Resurfacing and Tissue Histopathology After Ellacor Treatment | Biotech Hunter | Biotech Hunter